Three are the major unmet clinical needs in cáncer. To perform an integrative diagnosis with all technologies available, to find and validate prognostic and follow up biomarkers, and to better our molecular understanding of cáncer so new experimental therapies can be proposed. Potential collaborations with CIBER-BBN will be also discussed.